SEC Comment Letter 0000000000-23-013077 to Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260) (FBIO)
Fortress Biotech, Inc. (FBIO, FBIOP) (CIK 0001429260)
Date: Nov. 30, 2023 · CIK: 0001429260 · Accession: 0000000000-23-013077
AI Filing Summary & Sentiment
File numbers found in text: 001-35366
Letter
United States securities and exchange commission logo November 30, 2023 David Jin Chief Financial Officer Fortress Biotech, Inc. 1111 Kane Concourse, Suite 301 Bay Harbor Islands, Florida 33154 Re:Fortress Biotech, Inc. Form 10-K for Fiscal Year Ended December 31, 2022 Filed March 31, 2023 File No. 001-35366 Dear David Jin: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
November 30, 2023
David Jin
Chief Financial Officer
Fortress Biotech, Inc.
1111 Kane Concourse, Suite 301
Bay Harbor Islands, Florida 33154
Re:Fortress Biotech, Inc.
Form 10-K for Fiscal Year Ended December 31, 2022
Filed March 31, 2023
File No. 001-35366
Dear David Jin:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences